aids
Searching For HIV’s Achilles Heel
aids | biotechnology | hiv | infectious disease | science | virusWhy is it so hard to make an HIV vaccine? Dr. John Coffin, who is one of the fathers of modern retrovirology, Professor of Molecular Biology and Microbiology at Tufts University asks in his insightful blog article, full of humor and historical metaphors.
Genomic screen nets hundreds of human proteins exploited by HIV
aids | biotechnology | genes | genetics | hiv | scienceIn some ways, HIV resembles a minimalist painter, using a few basic components to achieve dramatic effects. The virus contains just nine genes encoding 15 proteins, which wreak havoc on the human immune system.
New insight into factors that drive muscle-building stem cells
aging | aids | bioengineering | biology | biomedical | biotechnology | science | stem cells | tissue engineeringA report in the January issue of Cell Metabolism, a publication of Cell Press, provides new evidence explaining how stem cells known as satellite cells contribute to building muscles up in response to exercise.
New HIV drug shows ‘unprecedented’ results
aids | biomedical | biotech | biotechnology | hiv | pharmaceuticalA new category of drug has shown promising results for HIV/AIDS patients who failed to respond to other treatments, a study to be shows. Especially when combined with other medications, raltegravir
3D Animation of HIV Replication
aids | animation | hiv | video | virusesThis is an outstanding 3D animation of HIV replication cycle. I especially loved the entry part, which is like watching a science fiction movie. The animation is fairly accurate representation of what we know about the this viruses life cycle today, except the part on entry of viral DNA into nucleus.
Scientists Crack the Genome of the Parasite Causing Trichomoniasis
aids | bioinformatics | genes | genome | hiv | infectious disease | parasiteScientists have finally deciphered the genome of the parasite causing trichomoniasis, a feat that is already providing new approaches to improve the diagnosis and treatment of this sexually transmitted disease.
Fighting HIV by Building a New Killer Frankenstein Virus
aids | bioengineering | biohacking | biomedical | hiv | vaccines | virusesIn order to find out how one of the world’s most devastating diseases overcomes state-of-the-art drugs, scientists led by Dr. Vineet KewalRamani at National Cancer Institute (NCI) are biohacking and re-engineering the HIV virus.
Researchers develop T-cells from human embryonic stem cells
aids | biotechnology | hiv | immune system | lymphocytes | stem cells | t cells | tissue engineeringResearchers from the UCLA AIDS Institute and the Institute for Stem Cell Biology and Medicine have demonstrated for the first time that human embryonic stem cells can be genetically manipulated and coaxed to develop into mature T-cells, raising hopes for a gene therapy to combat AIDS.
HIV-1’s high virulence might be an accident of evolution
aids | biotechnology | cell signaling | evolution | genes | hiv | immune system | lymphocytes | virusesThe virulence characteristic of HIV-1–the virus predominantly responsible for human AIDS–might amount to an accident of evolution, new evidence reveals. A gene function lost during the course of viral evolution predisposed HIV-1 to spur the fatal immune system failures that are the hallmarks of AIDS, researchers report in the June 16, 2006 Cell.
AIDS vaccine research offers new insights on survival in monkey models of HIV infection
aids | hiv | immune system | immunology | infection | lymphocytes | vaccinesNew insights into how a subpopulation of helper T-cells provides immunity and promotes survival following infection with an AIDS-like virus offer a new means of predicting an AIDS vaccine's effectiveness, a discovery that could help scientists as they test these vaccines in clinical trials.

